Prestige Consumer Healthcare Inc. (PBH)
Prestige Consumer Healthcare Inc. (NYSE: PBH) reported fiscal 2025 results with $1.138 billion in revenues (+1.1%), a 55.8% gross margin, operating income of $336.8 million and net income of $214.6 million (↑2.5%). North American OTC Healthcare (84.4% of sales) was flat, while International (15....